Tag archive for ‘Pfizer Inc. (NYSE: PFE; LSE: PFZ)’
Jewish Business News On Thursday, April 17th, 2014

Teva Settles Patent Litigation with Pfizer on arthritis treatment Celebrex

– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its subsidiary Teva Pharmaceuticals USA, Inc. has More...

Gali Weinreb On Sunday, March 16th, 2014

Protalix-Pfizer Collaboration Disappoints

– Sales of Protalix’s Gaucher’s disease drug to Pfizer totaled $4.4 million in 2013.  – – Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) is not yet seeing any substantial More...

Globes On Thursday, September 12th, 2013

Protalix Biotherapeutics plans $60 million US bond offering

–   The Gaucher and plant-cell treatment developer is offering a convertible note to US financial institutions. –   -/ By Nadav Neuman / Protalix Biotherapeutics Inc. (NYSE:PLX; TASE: PLX) More...

Wordpress site Developed by Fixing WordPress Problems